Assessment of neuromuscular and haemodynamic effects of cisatracurium and vecuronium under sevoflurane-remifentanil anaesthesia in elderly patients

European Journal of Anaesthesiology

Volumn 21, Issue 11, 2004, Pages 877-881

  Keleş, Gönül T ^a   Yentur A ^a   Cavus Z ^a   Sakarya, M ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Aged; Anaesthesia general, remifentanil, thiopental, sevoflurane; Neuromuscular blocking agents, vecuronium, cisatracurium, action duration, recovery

Indexed keywords

CISATRACURIUM; NITROUS OXIDE; OXYGEN; REMIFENTANIL; SEVOFLURANE; THIOPENTAL; VECURONIUM;

AGED; AGING; ANESTHESIA INDUCTION; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE COURSE; DOUBLE BLIND PROCEDURE; ENDOTRACHEAL INTUBATION; GENERAL ANESTHESIA; HEMODYNAMIC MONITORING; HEMODYNAMIC PARAMETERS; HEMODYNAMICS; HUMAN; MUSCLE RELAXATION; NEUROMUSCULAR BLOCKING; RANDOMIZED CONTROLLED TRIAL;

AGED; ANESTHESIA RECOVERY PERIOD; ANESTHETICS, INHALATION; ANESTHETICS, INTRAVENOUS; ATRACURIUM; BLOOD PRESSURE; DOUBLE-BLIND METHOD; FEMALE; HEART RATE; HEMODYNAMIC PROCESSES; HUMANS; INTUBATION, INTRATRACHEAL; MALE; METHYL ETHERS; MUSCLE RELAXATION; NEUROMUSCULAR BLOCKING AGENTS; NEUROMUSCULAR NONDEPOLARIZING AGENTS; PIPERIDINES; TIME FACTORS; VECURONIUM BROMIDE;

EID: 13244287733     PISSN: 02650215     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0265021504000225     Document Type: Article

References (21)

1. Jin F, Chung F. Minimizing perioperative adverse events in the elderly. Br J Anaesth 2001; 87: 608-624.
2. Delbono O. Neural control of aging skeletal muscle. Aging Cell 2003; 2: 21-29.
3. Vandervoort AA. Aging of the human neuromuscular system. Muscle Nerve 2002; 25: 17-25.
4. Viby-Mogensen J, Engbaek J, Eriksson LI, et al. Good clinical research practice (GCRP) in pharmacodynamic studies of neuromuscular blocking agents. Acta Anaesthesiol Scand 1996; 40: 59-74.
5. Kelly E, Lien CA, Savarese JJ, et al. Depression of neuromuscular function in a patient during desflurane anesthesia. Anesth Analg 1993; 76: 868-871.
6. Miller RD, Way WL, Dolan WM, et al. The dependence of pancuronium- and d-tubocurarine-induced neuromuscular blockades on alveolar concentrations of halothane and forane. Anesthesiology 1972; 37: 573-575.
7. Miller RD, Crique M, Eger EI. Duration of halothane anesthesia and neuromuscular blockade with d-tubocurarine. Anesthesiology 1976; 44: 206-208.
8. Vanlinthout LE, Booij LH, van Egmond J, Robertson EN. Effects of isoflurane and sevoflurane on the magnitude and time course of neuromuscular block produced by vecuronium, pancuronium and atracurium. Br J Anaesth 1996; 76: 389-395.
9. Miller RD, Rupp SM, Fisher DM, Cronnelly R, Fahey MR, Sohn YJ. Clinical pharmacology of vecuronium and atracurium. Anaesthesiology 1984; 61: 444-453.
10. Cannon JE, Fahey MR, Castagnoli KP, et al. Continuous infusion of vecuronium: the effect of anesthetics agents. Anesthesiology 1987; 67: 503-506.
11. Shanks CA, Fragen RJ, Ling D. Continuous intravenous infusion of rocuronium (ORG 9426) in patients receiving balanced, enflurane, or isoflurane anesthesia. Anesthesiology 1993; 78: 649-654.
12. Doherty TJ. Aging and sarcopenia. J Appl Physiol 2003; 95: 1717-1727.
13. Naguib M, Flood P, McArdle JJ, Brenner HR. Advances in neurobiology of the neuromuscular junction: implications for the anesthesiologist. Anesthesiology 2002; 96: 202-231.
14. De Wolf AM, Freeman JA, Scott VL, et al. Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation. Br J Anaesth 1996; 76: 624-628.
15. Ornstein E, Lien CA, Matteo RS, et al. Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical patients. Anesthesiology 1996; 84: 520-525.
16. Sorooshran SS, Stafford MA, Eastwood NB, et al. Pharmacokinetics and pharmacodynamics of cisatracurium in young and elderly adult patients. Anesthesiology 1996; 84: 1083-1091.
17. Boyd AH, Eastwood NB, Parker CJR, et al. Pharmacodynamics of the 1 R cis-1′R cis isomer of atracurium (51W89) in health and chronic renal failure. Br J Anaesth 1995; 74: 400-404.
18. Kitajima T, Ishii K, Ogata H. Edrophonium as an antagonist of vecuronium-induced neuromuscular block in the elderly. Anaesthesia 1995; 50: 359-361.
19. Pühringer FK, Heier T, Dodgson M, et al. Double-blind comparison of the variability in spontaneous recovery of cisatracurium and vecuronium induced neuromuscular block in adult and elderly patients. Acta Anaesthesiol Scand 2002; 46: 364-371.
20. Lien CA, Matteo RS, Ornstein E, Schwartz AE, Diaz J. Distribution, elimination, and action of vecuronium in the elderly. Anesth Analg 1991; 73: 39-42.
21. Debaene B, Plaud B, Dilly MP, Donati F. Residual paralysis in the PACU after a single intubating dose of nondepolarizing muscle relaxant with an intermediate duration of action. Anesthesiology 2003; 98: 1042-1048.